105 related articles for article (PubMed ID: 2669473)
1. Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin.
Singleton W; Dix RK; Monsen L; Moisey D; Levenstein M; Bottiglieri DF; Silver L
Am J Med; 1989 Aug; 87(2A):45S-52S. PubMed ID: 2669473
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
Deger G
Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
[TBL] [Abstract][Full Text] [Related]
4. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
5. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
9. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Cardiol; 1989 Sep; 64(11):65F-69F. PubMed ID: 2782273
[TBL] [Abstract][Full Text] [Related]
10. [Minipress in the treatment of arterial hypertension in light of results from a multicenter study. I. 3-month treatment: monotherapy versus combination treatment].
Sznajderman M
Kardiol Pol; 1989; 32(7-9):386-93. PubMed ID: 2701009
[TBL] [Abstract][Full Text] [Related]
11. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparative study of doxazosin and prazosin when administered with beta-blockers or diuretics.
de Planque BA
Am Heart J; 1991 Jan; 121(1 Pt 2):304-11. PubMed ID: 1670744
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system.
Gavras I; Mulinari R; Gavras H; Higgins JT; Reeves RL; Zawada ET; Crook J; Halperin AK; Garrett B
Am J Med; 1987 Dec; 83(6B):20-3. PubMed ID: 3332575
[TBL] [Abstract][Full Text] [Related]
14. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
Grzeszczak W
Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
[TBL] [Abstract][Full Text] [Related]
15. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
Dauer AD
Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
[TBL] [Abstract][Full Text] [Related]
16. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
17. Prazosin once or twice daily?
Westerman RF; Schouten JA; Hengeveld WL
Eur J Clin Pharmacol; 1985; 28(1):11-5. PubMed ID: 3987782
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
Kirby BJ; Kitchin NR
Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
[TBL] [Abstract][Full Text] [Related]
19. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
20. [Anti-hypertensive efficacy and tolerability of sustained-release prazosin hydrochloride. A Brazilian multicenter study].
Spritzer N
Arq Bras Cardiol; 1990 Oct; 55(4):263-6. PubMed ID: 2078143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
